Hepatocyte Growth Factors (HGFs) Market, By Product Type (Recombinant Hepatocyte Growth Factors, HGF Gene Therapy Products, Synthetic Peptide Derivatives, and Natural HGFs (Purified from Biological Sources)), By Type, By Source, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4483
|
Published Date
November 2025
|
Pages
394
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Hepatocyte Growth Factors (HGFs) Market size was valued at US$ 71,786.23 Million in 2024, expanding at a CAGR of 5.6% from 2025 to 2032.
The hepatocyte growth factor (HGF) market refers to the global ecosystem of products, technologies, and services used in the research, development, manufacturing, and application of these critical proteins. HGFs play essential roles in liver regeneration, embryonic development, tissue repair, angiogenesis, and tumor growth. They are extensively used in regenerative medicine, oncology, cellbased therapies, preclinical drug testing, and organ transplantation research. The market spans recombinant HGF proteins, HGF gene therapies, and hepatocyte-based cell culture products for both therapeutic and research applications. Governments around the world are actively supporting this field: for instance, the U.S. National Institutes of Health (NIH) invested US$2.54billion in regenerative medicine research between 2012 and 2014, which includes funding for growthfactor-based studies.
Hepatocyte Growth Factors (HGFs) Market- Market Dynamics
Rising Prevalence of Chronic Diseases to Drive Market Demand
The rising prevalence of chronic diseases is a key driver of the Hepatocyte Growth Factors (HGF) market. Conditions such as liver cirrhosis, hepatitis, cardiovascular disorders, and chronic kidney disease are increasing globally due to aging populations, sedentary lifestyles, and poor dietary habits. HGFs are essential for tissue regeneration, repair, and cell growth, making them valuable for treating these conditions. The growing demand for advanced regenerative therapies and biologics is fueling research, clinical trials, and product development in the HGF sector. As chronic diseases place a significant burden on healthcare systems, the need for effective, targeted therapies continues to drive market growth. In the United States, the Centers for Disease Control and Prevention (CDC) reported in 2024 that approximately 42% of adults have two or more chronic conditions, with 12% having at least five. These conditions account for nearly 90% of the nation’s annual healthcare expenditure of $4.1 trillion.
Hepatocyte Growth Factors (HGFs) Market- Key Insights
- According to analysis by our research team, the global HGF market is projected to grow at a CAGR of approximately 5.6% during the forecast period from 2025 to 2032.
- HGF gene therapy is expected to be the fastest-growing segment based on product type.
- In terms of source, human-derived HGFs are projected to dominate the market in 2025.
- Oncology is the fastest-expanding and leading application segment in 2025.
- Among end users, pharmaceutical and biotechnology companies are the primary consumers of HGF products in 2025.
- North America is anticipated to be the leading revenue-generating region in 2025.
Hepatocyte Growth Factors (HGFs) Market- Segmentation Analysis:
The Global Hepatocyte Growth Factors (HGFs) Market is segmented on the basis of Product Type, Type, Source, Application, End User, and Region.
The hepatocyte growth factor (HGF) market can be classified by product type into five segments: recombinant hepatocyte growth factors, natural HGFs purified from biological sources, synthetic peptide derivatives, HGF gene therapy products, and others. Among these, the HGF gene therapy products segment is expected to grow the fastest in the coming years. This rapid expansion is driven by its ability to deliver HGF directly to target cells or tissues—a feature particularly valuable in regenerative medicine and oncology. Gene therapy approaches minimize systemic exposure, thereby reducing side effects while improving therapeutic efficacy. Cuttingedge techniques such as CRISPRCas9 allow highly precise gene editing, enabling more effective and safer HGF-based gene therapies. The momentum is further strengthened by promising PhaseIII clinical trial results, which are boosting investor confidence and encouraging both public and private R&D investment.
In parallel, when considering the source of HGF, the market divides into four categories: humanderived, animalderived, synthetic/engineered sources, and others. The human-derived segment is expected to dominate in 2025. This dominance arises from its strong clinical relevance: human-derived HGFs are naturally produced in the body and play essential roles in physiological processes such as liver regeneration, tissue repair, and cell proliferation. They have shown promising potential in the treatment of liver diseases, heart failure, and neurological disorders. Their native biocompatibility makes them especially favorable in clinical trials and therapeutic applications. Moreover, advances in genetic engineering and stem-cell technologies are reinforcing this leadership by enabling more precise and efficient production of human-like HGF therapies. Government and regulatory support is playing a crucial role in driving growth in both these segments. For instance, in Japan, AnGes’s HGF gene therapy product (Collategene™, a naked plasmid DNA encoding human HGF) has received conditional and timelimited approval to treat critical limb ischemia, reflecting strong regulatory backing. Long-term follow-up of such gene therapy trials has shown safety and efficacy, with significant improvements in ulcer size and pain with minimal severe adverse events over two years. On a broader scale, governments around the world are increasingly funding gene therapy research. The U.S. National Institutes of Health (NIH), through its Bespoke Gene Therapy Consortium, has mobilized public-private collaborations to accelerate the development of tailored gene therapies.
Hepatocyte Growth Factors (HGFs) Market- Geographical Insights
North America dominates the hepatocyte growth factor (HGF) market, with the largest market share projected for 2025. This leadership is driven by the region’s advanced biotechnology industry, supportive regulatory environment, and growing awareness of HGF’s therapeutic potential. Factors such as an aging population and rising prevalence of chronic diseases have further fueled demand for HGFs. Additionally, North America’s robust healthcare infrastructure, strong focus on research and development, and presence of leading pharmaceutical and biotechnology companies have significantly contributed to market growth.
Asia Pacific is emerging as the fastest-growing region in the HGF market, driven by increasing chronic disease prevalence, expanding healthcare infrastructure, and rising healthcare expenditures. Governments in several Asian countries actively support pharmaceutical development and research through funding, regulatory streamlining, and incentives for clinical trials. Clinical trials in the region are generally more cost-effective than in Western countries, attracting international pharmaceutical companies. Moreover, the region’s large population base provides access to a substantial pool of potential clinical trial participants, further boosting market expansion.
Hepatocyte Growth Factors (HGFs) Market- Competitive Landscape:
The competitive landscape of the hepatocyte growth factor (HGF) market features several key players engaged in the research, development, and commercialization of HGF products. Companies in this market pursue competitive advantage through innovation, strategic partnerships, and expansion into emerging markets. The industry comprises a mix of established pharmaceutical firms, biotechnology companies, and research institutions, all contributing to the advancement of HGF applications across diverse therapeutic areas. The dynamic nature of the market fosters continuous research and development aimed at improving product efficacy, safety, and market reach. Leading players in the HGF market include Amgen Inc., Genentech Inc., and Eli Lilly and Company.
Recent Developments:
- May 2023: AnGes submitted a marketing application to Japan’s Ministry of Health, Labour, and Welfare for its gene therapy product Collategene, designed to treat leg ulcers caused by chronic arterial occlusion. Following conditional approval in March 2019, this new application seeks full approval based on evaluation results. If approved, Collategene will become the first product to have its conditions removed under Japan’s regenerative medicine approval system.
- July 2023: Lonza entered into a collaboration with ABL Bio, a South Korean biologics company specializing in bispecific antibodies for immuno-oncology and neurodegenerative diseases. The agreement supports the development and manufacturing of ABL Bio’s new bispecific antibody product.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- YooYoung Pharmaceutical Co., Ltd.
- F-star Therapeutics Inc.
- Creative BioMart
- ACROBiosystems
- Kringle Pharma
- Lonza Group
- Galaxy Bio Tech
- Merck KGaA (MilliporeSigma)
- F. Hoffmann-La Roche Ltd
- Galaxy Bio Tech
- Sino Biological Inc.
- Cell Signaling Technology
- R&D Systems (Bio-Techne)
- Origene Technologies
- Takara Bio Inc.
- GenScript Biotech Corporation
- Miltenyi Biotec
- BioVision Inc.
- Creative Biolabs
- Eli Lilly and Company (for gene therapy pipelines involving HGF)
- Others
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Recombinant Hepatocyte Growth Factors
- HGF Gene Therapy Products
- Synthetic Peptide Derivatives
- Natural HGFs (Purified from Biological Sources)
- Others
- Fusion Proteins
- Hybrid Growth Factors
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Preclinical
- Phase III (Ongoing)
- Phase II (Approved)
- Phase II (Ongoing)
- Phase I
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032
- Human-Derived
- Synthetic/Engineered Sources
- Animal-Derived
- Others
- Chimeric or Hybrid Constructs
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Regenerative Medicine
- Liver Regeneration
- Kidney Repair
- Wound Healing
- Cell Therapy & Stem Cell Research
- Toxicology and Preclinical Drug Testing
- Organ Transplantation Support
- Others
- Neurodegenerative Diseases
- Pulmonary Fibrosis
- Oncology
- Cancer Stem Cell Research
- Tumor Metastasis Studies
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- CROs (Contract Research Organizations
- Academic & Research Institutes
- Hospitals & Transplant Centers
- Others
- Diagnostic Labs
- Private Stem Cell Banks
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hepatocyte Growth Factors (HGFs) Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hepatocyte Growth Factors (HGFs) Market Snippet by Product Type
2.1.2. Hepatocyte Growth Factors (HGFs) Market Snippet by Type
2.1.3. Hepatocyte Growth Factors (HGFs) Market Snippet by Source
2.1.4. Hepatocyte Growth Factors (HGFs) Market Snippet by Application
2.1.5. Hepatocyte Growth Factors (HGFs) Market Snippet by End User
2.1.6. Hepatocyte Growth Factors (HGFs) Market Snippet by Country
2.1.7. Hepatocyte Growth Factors (HGFs) Market Snippet by Region
2.2. Competitive Insights
3. Hepatocyte Growth Factors (HGFs) Key Market Trends
3.1. Hepatocyte Growth Factors (HGFs) Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hepatocyte Growth Factors (HGFs) Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hepatocyte Growth Factors (HGFs) Market Opportunities
3.4. Hepatocyte Growth Factors (HGFs) Market Future Trends
4. Hepatocyte Growth Factors (HGFs) Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hepatocyte Growth Factors (HGFs) Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Hepatocyte Growth Factors (HGFs) Market Landscape
6.1. Hepatocyte Growth Factors (HGFs) Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hepatocyte Growth Factors (HGFs) Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Recombinant Hepatocyte Growth Factors
7.1.3. HGF Gene Therapy Products
7.1.4. Synthetic Peptide Derivatives
7.1.5. Natural HGFs (Purified from Biological Sources)
7.1.6. Others
7.1.6.1. Fusion Proteins
7.1.6.2. Hybrid Growth Factors
8. Hepatocyte Growth Factors (HGFs) Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
8.1.1.1. Preclinical
8.1.1.2. Phase III (Ongoing)
8.1.1.3. Phase II (Approved)
8.1.1.4. Phase II (Ongoing)
8.1.1.5. Phase I
9. Hepatocyte Growth Factors (HGFs) Market – By Source
9.1. Overview
9.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
9.1.1.1. Human-Derived
9.1.1.2. Synthetic/Engineered Sources
9.1.1.3. Animal-Derived
9.1.1.4. Others
9.1.1.4.1. Chimeric or Hybrid Constructs
10. Hepatocyte Growth Factors (HGFs) Market – By Application
10.1. Overview
10.1.1.1. Regenerative Medicine
10.1.1.1.1. Liver Regeneration
10.1.1.1.2. Kidney Repair
10.1.1.1.3. Wound Healing
10.1.1.2. Cell Therapy & Stem Cell Research
10.1.1.3. Toxicology and Preclinical Drug Testing
10.1.1.4. Organ Transplantation Support
10.1.1.5. Others
10.1.1.5.1. Neurodegenerative Diseases
10.1.1.5.2. Pulmonary Fibrosis
10.1.1.6. Oncology
10.1.1.6.1. Cancer Stem Cell Research
10.1.1.6.2. Tumor Metastasis Studies
11. Hepatocyte Growth Factors (HGFs) Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.2. CROs (Contract Research Organizations
11.1.1.3. Academic & Research Institutes
11.1.1.4. Hospitals & Transplant Centers
11.1.1.5. Others
11.1.1.5.1. Diagnostic Labs
11.1.1.5.2. Private Stem Cell Banks
12. Hepatocyte Growth Factors (HGFs) Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Hepatocyte Growth Factors (HGFs) Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Thermo Fisher Scientific
13.2.2. YooYoung Pharmaceutical Co., Ltd.
13.2.3. F-star Therapeutics Inc.
13.2.4. Creative BioMart
13.2.5. ACROBiosystems
13.2.6. Kringle Pharma
13.2.7. Lonza Group
13.2.8. Galaxy Bio Tech
13.2.9. Merck KGaA (MilliporeSigma)
13.2.10. F. Hoffmann-La Roche Ltd
13.2.11. Galaxy Bio Tech
13.2.12. Sino Biological Inc.
13.2.13. Cell Signaling Technology
13.2.14. R&D Systems (Bio-Techne)
13.2.15. Origene Technologies
13.2.16. Takara Bio Inc.
13.2.17. GenScript Biotech Corporation
13.2.18. Miltenyi Biotec
13.2.19. BioVision Inc.
13.2.20. Creative Biolabs
13.2.21. Eli Lilly and Company (for gene therapy pipelines involving HGF)
13.2.22. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- YooYoung Pharmaceutical Co., Ltd.
- F-star Therapeutics Inc.
- Creative BioMart
- ACROBiosystems
- Kringle Pharma
- Lonza Group
- Galaxy Bio Tech
- Merck KGaA (MilliporeSigma)
- F. Hoffmann-La Roche Ltd
- Galaxy Bio Tech
- Sino Biological Inc.
- Cell Signaling Technology
- R&D Systems (Bio-Techne)
- Origene Technologies
- Takara Bio Inc.
- GenScript Biotech Corporation
- Miltenyi Biotec
- BioVision Inc.
- Creative Biolabs
- Eli Lilly and Company (for gene therapy pipelines involving HGF)
- Others
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Recombinant Hepatocyte Growth Factors
- HGF Gene Therapy Products
- Synthetic Peptide Derivatives
- Natural HGFs (Purified from Biological Sources)
- Others
- Fusion Proteins
- Hybrid Growth Factors
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Preclinical
- Phase III (Ongoing)
- Phase II (Approved)
- Phase II (Ongoing)
- Phase I
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032
- Human-Derived
- Synthetic/Engineered Sources
- Animal-Derived
- Others
- Chimeric or Hybrid Constructs
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Regenerative Medicine
- Liver Regeneration
- Kidney Repair
- Wound Healing
- Cell Therapy & Stem Cell Research
- Toxicology and Preclinical Drug Testing
- Organ Transplantation Support
- Others
- Neurodegenerative Diseases
- Pulmonary Fibrosis
- Oncology
- Cancer Stem Cell Research
- Tumor Metastasis Studies
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- CROs (Contract Research Organizations
- Academic & Research Institutes
- Hospitals & Transplant Centers
- Others
- Diagnostic Labs
- Private Stem Cell Banks
GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
